274 related articles for article (PubMed ID: 7932164)
21. Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites.
Gregus Z; Madhu C; Klaassen CD
J Pharmacol Exp Ther; 1988 Jan; 244(1):91-9. PubMed ID: 3336012
[TBL] [Abstract][Full Text] [Related]
22. Sulfation and sulfotransferases 5: the importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation.
Klaassen CD; Boles JW
FASEB J; 1997 May; 11(6):404-18. PubMed ID: 9194521
[TBL] [Abstract][Full Text] [Related]
23. Alteration in the biliary and urinary excretion of acetaminophen metabolites by nephrotoxicants in rats.
Seo KW; Choung SY; Park KS; Kim HJ
Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):305-17. PubMed ID: 9144837
[TBL] [Abstract][Full Text] [Related]
24. Effects of variation in the dietary supply of cysteine and methionine on liver concentration of glutathione and "active sulfate" (PAPS) and serum levels of sulfate, cystine, methionine and taurine: relation to the metabolism of acetaminophen.
Glazenburg EJ; Jekel-Halsema IM; Scholtens E; Baars AJ; Mulder GJ
J Nutr; 1983 Jul; 113(7):1363-73. PubMed ID: 6864334
[TBL] [Abstract][Full Text] [Related]
25. Measurement of contribution from intracellular cysteine to sulfate in phosphoadenosine phosphosulfate in rat ovarian granulosa cells.
Imai Y; Yanagishita M; Hascall VC
Arch Biochem Biophys; 1994 Aug; 312(2):392-400. PubMed ID: 8037451
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent intestinal glucuronidation and sulfation of acetaminophen in the rat in situ.
Goon D; Klaassen CD
J Pharmacol Exp Ther; 1990 Jan; 252(1):201-7. PubMed ID: 2299589
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the 3'-phosphoadenosine 5'-phosphosulfate (PAPS) transporter 1 increases sulfation of chondroitin sulfate in the apical pathway of MDCK II cells.
Dick G; Grøndahl F; Prydz K
Glycobiology; 2008 Jan; 18(1):53-65. PubMed ID: 17965432
[TBL] [Abstract][Full Text] [Related]
28. Effect of experimental renal failure on sulfate retention and acetaminophen pharmacokinetics in rats.
Lin JH; Levy G
J Pharmacol Exp Ther; 1982 Apr; 221(1):80-4. PubMed ID: 7062293
[TBL] [Abstract][Full Text] [Related]
29. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction.
Gregus Z; Madhu C; Klaassen CD
Drug Metab Dispos; 1990; 18(1):10-9. PubMed ID: 1970767
[TBL] [Abstract][Full Text] [Related]
30. Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin.
Watkins JB; Sherman SE
J Pharmacol Exp Ther; 1992 Mar; 260(3):1337-43. PubMed ID: 1545396
[TBL] [Abstract][Full Text] [Related]
31. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
Brouwer KL; Jones JA
J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation.
Fayz S; Cherry WF; Dawson JR; Mulder GJ; Pang KS
Drug Metab Dispos; 1984; 12(3):323-9. PubMed ID: 6145559
[TBL] [Abstract][Full Text] [Related]
33. Effects of cysteine and acetaminophen on the syntheses of glutathione and adenosine 3'-phosphate 5'-phosphosulfate in isolated rat hepatocytes.
Dalhoff K; Poulsen HE
Biochem Pharmacol; 1992 Aug; 44(3):447-54. PubMed ID: 1510695
[TBL] [Abstract][Full Text] [Related]
34. Effect of reduced hepatic energy state on acetaminophen conjugation in rats.
Dills RL; Klaassen CD
J Pharmacol Exp Ther; 1986 Aug; 238(2):463-72. PubMed ID: 3735128
[TBL] [Abstract][Full Text] [Related]
35. Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: effect of chemicals that alter acetaminophen hepatotoxicity.
Madhu C; Gregus Z; Klaassen CD
J Pharmacol Exp Ther; 1989 Mar; 248(3):1069-77. PubMed ID: 2703963
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous measurements of glutathione and activated sulphate (PAPS) synthesis rates and the effects of selective inhibition of glutathione conjugation or sulphation of acetaminophen.
Dalhoff K; Poulsen HE
Biochem Pharmacol; 1993 Aug; 46(3):383-8. PubMed ID: 8347163
[TBL] [Abstract][Full Text] [Related]
37. Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats.
Price VF; Jollow DJ
Toxicol Appl Pharmacol; 1989 Nov; 101(2):356-69. PubMed ID: 2815088
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant.
Miller MG; Beyer J; Hall GL; deGraffenried LA; Adams PE
Toxicol Appl Pharmacol; 1993 Sep; 122(1):108-16. PubMed ID: 8378925
[TBL] [Abstract][Full Text] [Related]
39. Effect of sulfhydryl-deficient diets on hepatic metallothionein, glutathione, and adenosine 3'-phosphate 5'-phosphosulfate (PAPS) levels in rats.
Sendelbach LE; White CA; Howell S; Gregus Z; Klaassen CD
Toxicol Appl Pharmacol; 1990 Feb; 102(2):259-67. PubMed ID: 2300970
[TBL] [Abstract][Full Text] [Related]
40. The differential effects of hepatotoxicants on the sulfation pathway in rats.
Maziasz TJ; Liu J; Madhu C; Klaassen CD
Toxicol Appl Pharmacol; 1991 Sep; 110(3):365-73. PubMed ID: 1949007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
